Byung-Ha Kim

Title: Byung-Ha Kim: Innovator in Pharmaceutical Composition

Introduction

Byung-Ha Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug compositions. His work focuses on enhancing the stability and efficacy of pharmaceutical formulations.

Latest Patents

Byung-Ha Kim holds a patent for an oral pharmacological composition that includes a novel compound, 5-{4-(amino sulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone. This compound is characterized by its crystalline structure, which offers excellent stability. The patent outlines a pharmaceutical composition that includes this compound as a major ingredient, along with a pharmaceutically acceptable diluent and lubricant. The advantages of this composition include good stability, high dissolution rate, improved content uniformity, and excellent pharmacokinetic properties. It is particularly effective as a non-steroidal anti-inflammatory drug for treating inflammation or pain.

Career Highlights

Byung-Ha Kim is associated with Crystalgenomics, Inc., where he continues to innovate in the pharmaceutical sector. His work has led to advancements in drug formulations that are crucial for patient care and treatment efficacy.

Collaborations

He collaborates with notable colleagues such as Sik Ii Ahn and Jae-yeon Park, contributing to a dynamic research environment that fosters innovation.

Conclusion

Byung-Ha Kim's contributions to pharmaceutical compositions demonstrate his commitment to improving drug stability and efficacy. His innovative work continues to impact the field positively.